It will be provided as a weekly self-administered injection and is to be used alongside usual medications, such as statins, as well as lifestyle changes
Using semaglutide as a weight-loss medication has been successful in clinical trials
In the STEP 4 trial, participants who achieved significant weight loss on semaglutide 2.4 mg were randomized to either continue the medication or switch to placebo
ORFORGLIPRON Eli Lilly (the manufacturer of Mounjaro), has its own oral GLP-1 drug, orforglipron, that according to Eli Lilly, shows people without type two diabetes seeing weight reduction between 14% and 15% over the course of 36 weeks, whereas those with type two diabetes saw weight loss of about 9.6% over the same time frame
When the next grey-market vendor disappears, and one will, having a trusted knowledge base and community makes the difference between scrambling and adapting